Source: Medicines Authority (MT) Revision Year: 2021 Publisher: Les Laboratoires Servier, 50, rue Carnot, 92284 Suresnes cedex, France
Hypertension.
The recommended dosage is 1 tablet daily as a single morning dose.
In the event of insufficient results after one month of treatment, the dosage may be increased to 2 tablets daily in 2 doses (one in the morning and one in the evening) at the beginning of meals.
Given its good clinical and biological acceptability, Hyperium may be administered to elderly and diabetic patients.
Treatment may be continued indefinitely.
In patients with renal insufficiency, a dosage adjustment is in principle not necessary if the creatinine clearance is greater than 15 ml/min.
Due to the lack of clinical experience, the use of Hyperium in children is not recommended.
Data related to a massive ingestion are very limited. The most likely expected symptoms in this case would be marked hypotension and disorders of vigilance.
The treatment must be symptomatic. In addition to gastric lavage, the recommended treatment may involve the use of sympathomimetics agents in case of marked hypotension. Hyperium is weakly dialyzable.
2 years.
Do not store above 30°C.
Boxes of 10, 15, 20 or 30 tablets in blister packs (Aluminium/Polyamide/PVC).
Not all pack sizes may be marketed.
No special requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
